— Know what they know.
Not Investment Advice
Also trades as: 0A23.L (LSE) · $vol 0M

PHR NYSE

Phreesia, Inc.
1W: +0.1% 1M: -5.8% 3M: -30.9% YTD: -46.1% 1Y: -65.6% 3Y: -71.8% 5Y: -80.8%
$8.92
+0.14 (+1.59%)
After Hours: $8.95 (+0.03, +0.34%)
Weekly Expected Move ±7.7%
$7 $8 $9 $9 $10
NYSE · Healthcare · Medical - Healthcare Information Services · Alpha Radar Strong Sell · Power 37 · $551.0M mcap · 49M float · 3.91% daily turnover · Short 36% of daily vol

Cash Flow Trends

Operating Cash Flow
$79M +143.4% ▲
5Y CAGR: +93.7%
Capital Expenditures
$11M +53.9% ▲
5Y CAGR: -9.8%
Free Cash Flow
$68M +716.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$10M -214.8% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income-$118M-$176M-$137M-$59M$2M
Depreciation & Amort.$21M$25M$29M$28M$31M
Stock-Based Comp.$36M$59M$72M$67M$67M
Change in Working Capital-$19M-$4M-$2M-$6M-$14M
Other Non-Cash Items$4M$5M$5M$2M$5M
Operating Cash Flow-$75M-$90M-$32M$32M$79M
— Investing Activities —
Capital Expenditures-$31M-$26M-$6M-$9M-$11M
Acquisitions (Net)-$34M$0-$15M$0-$153M
Investment Purchases$0$0$0$0$16M
Investment Sales$0$0$0$0$0
Other Investing-$12M-$21M-$19M-$15M-$13M
Investing Cash Flow-$65M-$26M-$40M-$24M-$162M
— Financing Activities —
Net Debt Issuance-$4M-$6M-$7M-$8M$83M
Stock Repurchased-$9M-$19M-$12M$0$0
Dividends Paid$0$0$0$0$0
Other Financing$2M-$20M$2M-$8M-$14M
Financing Cash Flow$235M-$20M-$17M-$11M$73M
Net Change in Cash$95M-$137M-$89M-$3M-$10M
Cash End of Period$314M$177M$88M$84M$74M
Free Cash Flow-$106M-$116M-$57M$8M$68M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms